Cover Image

Guidance for industry : FDA export certificates.

Bibliographic Details
Corporate Authors:	Center for Biologics Evaluation and Research (U.S.), Center for Drug Evaluation and Research (U.S.), Center for Devices and Radiological Health (U.S.), Center for Veterinary Medicine (U.S.), Center for Food Safety and Applied Nutrition (U.S.)
Format:	Government Document eBook
Language:	English
Published:	Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research : Center for Drug Evaluation and Research : Center for Devices and Radiological Health : Center for Veterinary Medicine : Center for Food Safety and Applied Nutrition, [2005]
Subjects:	Export controls > United States. Biologicals > Government policy > United States. Medical instruments and apparatus > Government policy > United States.
Online Access:	https://purl.fdlp.gov/GPO/LPS113005

Similar Items

Guidance for industry and FDA staff : early development considerations for innovative combination products.
Published: (2006)

Guidance for industry : use of sterile connecting devices in blood bank practices.
Published: (2000)

Guidance for FDA reviewers : premarket notification submissions for transfer sets (excluding sterile connecting sets).
Published: (2001)

Guidance for industry : class II special controls guidance document : cord blood processing system and storage container.
Published: (2007)

Guidance for industry, FDA staff, and FDA-accredited third parties.
Published: (2009)

FDA's clearance of medical devices through the 510(k) process.
Published: (2013)

Guidance for industry and FDA staff : devices used to process human cells, tissues, and cellular and tissue-based products (HCT/Ps).
Published: (2007)

Guidance for sponsors, industry, researchers, investigators, and Food and Drug Administration staff : certifications to accompany drug, biological product and device applications/submissions : compliance with Section 402(j) of the Public Health Service Act, added by Title VIII of the Food and Drug Administration Amendments Act of 2007.
Published: (2009)

Guidance for FDA reviewers : premarket notification submissions for blood and plasma warmers.
Published: (2001)

Guidance for industry : exports under the FDA Export Reform and Enhancement Act of 1996.
Published: (2007)

Information sheet guidance for IRBs, clinical investigators, and sponsors : frequently asked questions about medical devices.
Published: (2006)

FDA and industry actions on premarket approval applications (PMAs), effect on FDA review clock and goals.
Published: (2008)

Guidance for industry : patient-reported outcome measures, use in medical product development to support labeling claims.
Published: (2006)

Federal policies and the medical devices industry.
Published: (1984)

Federal policies and the medical devices industry.
Published: (1984)

Guidance for industry and staff : resolution of disputes concerning payment or refund of medical device user fees under MDUFMA.
Published: (2004)

Federal policies and the medical devices industry : summary.
Published: (1984)

Federal policies and the medical devices industry : summary.
Published: (1984)

Information sheet guidance for IRBs, clinical investigators, and sponsors : significant risk and nonsignificant risk medical device studies.
Published: (2006)

Implementation of the Inspection by Accredited Persons Program under the Medical Device User Fee and Modernization Act of 2002, accreditation criteria.
Published: (2004)

Federal policies and the medical devices industry /
Published: (1984)

User fees and refunds for premarket approval applications.
Published: (2003)

FDA and the medical device industry : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, second session, February 26, 1990.
Published: (1990)

FDA medical device approval : is there a better way? : hearing before the Subcommittee on Health Care, District of Columbia, Census, and the National Archives of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Twelfth Congress, first session, June 2, 2011.
Published: (2011)

FDA medical device approval : is there a better way? : hearing before the Subcommittee on Health Care, District of Columbia, Census, and the National Archives of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Twelfth Congress, first session, June 2, 2011.
Published: (2011)

Guidance for industry and FDA staff : expedited review of premarket submissions for devices.
Published: (2008)

Reinventing drug and medical device regulation.
Published: (1995)

Premarket approval application filing review.
Published: (2003)

Real-time premarket approval application (PMA) supplements.
Published: (2006)

Premarket approval application modular review.
Published: (2003)

Medical device regulation : too early to assess European system's value as model for FDA : report to the Chairman, Committee on Labor and Human Resources, U.S. Senate /
Published: (1996)

Guidance for industry : drugs, biologics and medical devices derived from bioengineered plants for use in humans and animals.
Published: (2002)

Draft guidance for industry and FDA : consumer-directed broadcast advertising of restricted devices.
Published: (2004)

CMS regulation of healthcare services : hearing before the Committee on Small Business, House of Representatives, One Hundred Seventh Congress, second session, Washington, DC, October 3, 2002.
Published: (2002)

CMS regulation of healthcare services : hearing before the Committee on Small Business, House of Representatives, One Hundred Seventh Congress, second session, Washington, DC, October 3, 2002.
Published: (2002)

Medicare's competitive bidding program for durable medical equipment : implications for quality, cost and access : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, second session, September 15, 2010.
Published: (2013)

User fees and refunds for premarket notification submissions (510(k)s).
Published: (2004)

Regulating innovation : FDA's medical device approval process : hearing before the Subcommittee on Investigations and Oversight of the Committee on Science, Space, and Technology, U.S. House of Representatives, One Hundred Third Congress, first session, September 17, 1993.
Published: (1994)

Hearing on the Medicare durable medical equipment competitive bidding program : hearing before the Subcommittee on Health of the Committee on Ways and Means, U.S. House of Representatives, One Hundred Twelfth Congress, second session, May 9, 2012.
Published: (2013)

Medical device safety : how FDA regulates the reprocessing of supposedly single-use devices : hearing before the Committee on Government Reform, House of Representatives, One Hundred Ninth Congress, second session, September 26, 2006.
Published: (2006)